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ORIGINAL ARTICLE
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Abstract
Background: Pneumonia is a major, complicated disease in patients with
dementia. However, the influence of pneumonia on the prognosis of patients
with varying types of dementia has not been fully evaluated.
Methods: We retrospectively analyzed the data from medical and autopsy
reports. All study patients had been hospitalized and underwent brain
autopsy in a hospital in Toyohashi, Japan, between 2005 and 2014. The
patients with subtypes of dementia, specifically Alzheimer’s disease (AD),
dementia with Lewy bodies (DLB), or vascular dementia (VaD), were
neuropathologically diagnosed and examined. Pneumonia incidence, cause
of death, and the clinical time-course of dementia were compared among
the dementia subtypes. The time to death from dementia onset (survival
time) was compared by the Kaplan–Meier method among subtypes of
dementia with or without pneumonia. Risk factors for survival time on all
study patients were analyzed with the Cox proportional hazard model.
Results: Of the 157 eligible patients, 63 (40.1%) had AD, 42 (26.8%) had
DLB, and 52 (33.1%) had VaD. Pneumonia complication was observed with
high incidence in each subtype of dementia, especially in DLB (90.5%). The
median total duration from dementia onset to death was 8 years in AD and
DLB, and 5 years in VaD. The VaD subtype had more male patients than AD
or DLB (P = 0.010), and age of death in this group was the youngest among
the three groups (P = 0.018). A significant difference was observed in the
survival time by the Kaplan–Meier method among the three groups (P <
0.001) and among the groups with pneumonia (P = 0.002). The factors
associated with shorter survival time were male gender, pneumonia compli-
cations, diabetes mellitus, age of dementia onset ≥ 75 years, and VaD.
Conclusions: Pneumonia complications shortened the survival time of
patients with AD, DLB, and VaD.
Keywords: Alzheimer’s disease, dementia with
Lewy bodies, dementia, diabetes mellitus,
pneumonia, survival time, vascular dementia.
INTRODUCTION
Dementia has become an illness of major concern
among the ageing population globally. Although there
is individual variability in the clinical course of demen-
tia, the disease decreases people’s life expectancy.1–4
The primary cause of death in dementia patients is
pneumonia, whereas cardiovascular disease and neo-
plasms are more common in the general population.4–7
A recent meta-analysis indicated that the odds
of pneumonia-associated death were increased in
persons with dementia.8 Although few reports have
investigated the association between respiratory
function and dementia,9–11 a current UK study demon-
strated an association between forced expiratory
volume in 1 s and dementia-related death.12 We
hypothesized that if deterioration in pulmonary func-
tion contributes to death in dementia, dementia
patients who develop pneumonia will have shorter
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lifespans than those without pneumonia. Understand-
ing the influence of pneumonia on clinical time-course
of dementia is crucial for predicting the remaining life
in patients with dementia and contributes to the
development of optimal clinical management of
dementia.
Currently, there are three major subtypes of
dementia: Alzheimer’s disease (AD), dementia with
Lewy bodies (DLB), and vascular dementia (VaD).
Approximately 90% of the total dementia population
in Japan has one of these forms of dementia.13–15
Previous reports indicated the varied survival time of
patients with each dementia subtype.16–18 Compari-
sons of survival time between AD and DLB have been
inconsistent, with studies showing faster,19 slower,20
or no difference.21–24 The disease progression of AD,
DLB, and VaD with and without pneumonia has not
previously been elucidated and remains unclear.
However, some discrepancies between the clinical
and neuropathological diagnoses of each subtype of
dementia sometimes make it difficult to interpret the
results of such studies.4–7
The aims of the present study were to examine the
survival time in AD, DLB, and VaD, with and without
pneumonia, and to determine the risk factors affecting
the time from dementia onset to death.
METHODS
Study design and subjects
The study was conducted at the Choju Medical
Institute, Fukushimura Hospital in Toyohashi,
Japan, which mainly specializes in psychogeriatrics,
neurology, internal medicine, and surgery, and
includes a neuropathological research centre.14
We retrospectively reviewed the charts, medical
reports, and autopsy reports, as well as the results of
neuropathological examinations, of patients who
were hospitalized and deceased between January
2005 and December 2014. All patients had brain
autopsies in the neuropathological research centre at
the study site. Data were collected in relation to the
general and clinical backgrounds of the patients, clini-
cal time-courses, and clinical conditions of patients
during the hospitalization, including swallowing dys-
function, nosocomial infections, percutaneous endo-
scopic gastrostomy, medications, and results of
neuropathological examinations.
From the autopsied cases, patients with
neuropathological diagnosis of AD, DLB, or VaD by
specialized pathologists and neurologists were
selected for the study. For cases with both AD and
Lewy pathology, low likelihood cases with extensive
AD pathology according to the DLB guideline were
considered to have AD.25–27 In addition, cases with
both AD and vascular pathology (i.e. mixed dementia)
were considered to have AD.
The clinical and general backgrounds, the inci-
dence of pneumonia, underlying and immediate
causes of death, and clinical time-courses were
compared among the three subtypes of dementia.
The risk factors for the time to death from dementia
onset (survival time) were analyzed for all eligible
patients, as well as between patients with and
without pneumonia.
The study was approved by the institutional
review boards of the University of Tsukuba and
the Choju Medical Institute, Fukushimura Hospital.
Written informed consent was obtained from patients’
relatives.
Diagnosis and definitions
Two investigators independently reviewed the data
and were blinded to the clinical diagnoses written by
the physician in charge in order to ensure the demen-
tia subtype and cause of death were accurate. The
cause of death, dementia subtype, and other vari-
ables were extracted into predesigned data collection
forms. We verified the accuracy of the data by com-
paring the collection forms from each investigator.
Any discrepancy was resolved by discussion.
The neuropathological diagnosis of AD, DLB and
VaD was assessed with autopsy records and based
on published criteria, including the Consortium to
Establish a Registry for Alzheimer’s Disease,28–30
Braak scores,31 and neurofibrillary tangles as
described by Mölsä et al.,32 DLB guidelines,25–27 and
Kosaka’s classification.33,34
Based on the diagnostic criteria of guidelines for
the management of hospital-acquired pneumonia in
adults by the Japanese Respiratory Society, the com-
plication of pneumonia may occur either repeatedly or
once during hospitalization.35
Dementia onset was defined at the time (year) when
patients first experienced forgetfulness, disorienta-
tion, abnormal behaviour, or delusions according to
the Guideline for Dementia 2010.36 Hospital admission
was defined as the time of hospitalization until the
patient was discharged.
T. Manabe et al.
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The immediate cause of death was defined as the
final disease, injury, or complication directly causing
death. The underlying cause of death was defined as
the disease, injury, or corresponding circumstances
that initiated the chain of events ultimately leading to
death.5
Statistical analysis
The data relating to the general and clinical back-
grounds of the patients, clinical time-courses includ-
ing time to death from dementia onset, time to
hospital admission from dementia onset, time to
death from hospital admission, and causes of death
were summarized and compared among groups of
each subtype of dementia. The Kruskal–Wallis tests
were used for continuous variables, and the χ2 and
Fisher’s exact tests were used for categorical vari-
ables. Survival curves on the survival times of demen-
tia (years) in groups of patients with AD, DLB, or VaD,
with or without pneumonia, were analyzed by the
Kaplan–Meier method, and comparisons were made
with the log-rank test. To evaluate independent
factors for the survival time of dementia, a stepwise
method was used for a Cox proportional hazard
analysis. Data analyses were conducted using SPSS
Statistics 22.0 (IBM, Armonk, NY, USA). For all analy-
ses, significance levels were two-tailed, and P < 0.05
was considered significant.
RESULTS
General characteristics of study patients with
AD, DLB, and VaD
During the observation period, a total of 261 patients
died and were autopsied at Fukushimura Hospital
(Fig. 1). Patients who died within 1 week of an emer-
gency visit to the hospital and who did not have data
available were excluded from the study; therefore, the
study included a total 230 patients. Among them, 157
patients were determined to have AD, DLB, or VaD by
neuropathological diagnosis. The numbers of each
subtype of dementia were 63 AD (40.1%), 42 DLB
(26.8%), and 52 VaD (33.1%).
The general characteristics of the patients with AD,
DLB, and VaD are shown in Table 1. While more
female patients had AD and DLB, more male patients
had VaD. The age of dementia onset among VaD
Figure 1 Study population. A total of 261 patients were autopsied at the study site during the observational period. Patients who died within
1 week of an emergency visit to the hospital and who did not have data available were excluded. In total, 157 patients were determined to
have Alzheimer’s disease, dementia with Lewy bodies, or vascular dementia by neuropathological diagnoses and were eligible for the present
study.
Pneumonia and prognosis of dementia
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patients tended to be younger than among AD and
DLB patients, but there was no significant difference
among the subtypes of dementia. A high incidence of
pneumonia complication was seen in all three sub-
types of dementia, with no significant difference
among the three groups. DLB patients had the highest
incidence (90.5%) of pneumonia complication. Cere-
bral infarction, including asymptomatic condition, was
pathologically found in 82.7% of VaD patients, and
there was also a high incidence in AD and DLB
patients. The major comorbidities were hypertension
and diabetes mellitus, especially in patients with
VaD.
Causes of death in patients with AD, DLB,
and VaD
The underlying and immediate causes of death were
examined and compared among the subtypes of
dementia (Table 2). Although the causes of death in
dementia patients varied, pneumonia was the great-
est underlying and immediate cause of death. In
49.2% of AD patients, pneumonia was the underlying
cause of death (P = 0.001), and in over 50% of AD and
DLB patients, it was the immediate cause of death (P
= 0.007); there was significant difference among the
subtypes of dementia. More VaD and DLB patients
than AD patients had respiratory failure as the imme-
diate cause of death (P = 0.056). Renal failure was the
second highest immediate cause of death among VaD
patients, with a significant difference among the sub-
types (P = 0.046). Sudden death only presented in
DLB as an immediate cause of death.
Clinical time-course of dementia in patients with
and without pneumonia
The clinical time-courses of dementia patients were
compared among the subtypes of dementia and
between patients with and without pneumonia
(Table 3). Although there was no difference in the age
of dementia onset among the three groups, the age of
Table 1 General characteristics of patients with Alzheimer’s disease, dementia with Lewy bodies, or vascular dementia (n = 157)
AD DLB VaD
P-valuen = 63 n = 42 n = 52
Complication of pneumonia, n (%) 56 (88.9) 38 (90.5) 43 (82.7) 0.306†
Gender, n (%) 0.010†
Male 20 (31.7) 12 (28.6) 27 (51.9)
Female 43 (68.3) 30 (71.4) 25 (48.1)
Age
Median age in years of dementia onset (IQR) 79 (72–84) 78 (72–84) 76 (70–82) 0.269§
<65 years, n (%) 8 (12.7) 4 (9.5) 6 (11.5) 0.125†
65–74 years, n (%) 11 (17.5) 9 (21.4) 17 (32.7)
≥75 years, n (%) 44 (69.8) 29 (69.0) 29 (55.8)
Clinical characteristics
Median BMI at admission (IQR) (n = 77) 19 (16–20) 18 (14–21) 19 (18–22) 0.096§
Median weight of brain (IQR) (n = 135) 1047 (980–1170) 1050 (1000–1140) 1080 (982–1153) 0.062§
Pathological findings, n (%)
Cerebral infarction 27 (42.9) 15 (35.7) 43 (82.7) <0.001†
Comorbidities, n (%)
Hypertension 27 (42.9) 11 (26.2) 31 (59.6) 0.001†
Pulmonary emphysema 11 (17.5) 8 (19.0) 10 (19.2) 0.853†
Diabetes mellitus 10 (15.9) 2 (4.8) 14 (26.9) 0.007†
Angina 5 (8.1) 3 (6.5) 3 (6.5) 0.801‡
Heart failure 5 (8.1) 2 (4.3) 2 (3.8) 0.507‡
Malignant neoplasm 10 (16.1) 2 (4.3) 4 (7.7) 0.047†
Events after admission, n (%)
PEG 19 (30.2) 17 (40.5) 25 (48.1) 0.046†
Urinary tract infection 10 (16.1) 9 (19.6) 8 (15.4) 0.521†
Swallowing dysfunctions 26 (41.3) 23 (54.8) 23 (44.2) 0.157†
Medications, n (%)
Anti-dementia drug* 12 (19.4) 3 (6.5) 2 (3.8) 0.007†
Benzodiazepines use 6 (9.7) 9 (19.6) 7 (13.5) 0.143†
*Anti-dementia drug included acetylcholine inhibitors and NMDA receptor inhibitor. †χ2 test. ‡Fisher’s exact test. §Kruskal–Wallis test. AD, Alzheimer’s disease;
BMI, body mass index; DLB, dementia with Lewy bodies; IQR, interquartile range; PEG, percutaneous endoscopic gastrostomy; VaD, vascular dementia.
T. Manabe et al.
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death of VaD patients was younger than that of AD
and DLB patients (P = 0.018). The median survival
time for VaD patients was shorter (5 years) than for AD
(8 years) and DLB (8 years) patients. Although the
number of patients with DLB who did not acquire
pneumonia was small, their lifespan was shortened by
5 years if they developed pneumonia (13 vs 8 years).
In the analysis on the divided survival time-course, a
significant difference was seen between the subtypes
of dementia in the time from dementia onset to hos-
pital admission, but no difference was observed in the
time from hospital admission to death.
The influence of the complication of pneumonia
on clinical time-courses was assessed by the
Table 2 Immediate and underlying cause of death in dementia patients with and without pneumonia (n = 157)
AD DLB VaD
P-valuen = 63 n = 42 n = 52
Underlying cause of death, n (%)
Pneumonia 31 (49.2) 9 (21.4) 15 (28.8) 0.001†
Cerebrovascular accident 6 (9.7) 3 (7.1) 6 (11.5) 0.405‡
Heart failure 9 (14.5) 13 (28.3) 6 (11.5) 0.006†
Respiratory failure 1 (1.6) 1 (2.2) 2 (3.8) 1.000‡
Renal failure 1 (1.6) 2 (4.3) 5 (9.6) 0.051†
Failure on liver, gallbladder, pancreas 2 (3.2) 2 (4.3) 1 (1.9) 1.000‡
Diabetes mellitus 1 (1.6) 3 (6.5) 0 (0.0) 0.101†
Malignant neoplasm 5 (8.1) 6 (13.0) 6 (11.5) 0.274†
Sepsis 3 (4.8) 3 (6.5) 7 (13.5) 0.061†
Geromarasmus 1 (1.6) 1 (2.2) 0 (1.3) 1.000‡
Sudden unexpected natural death 0 (0.0) 1 (2.2) 0 (0.0) 0.268‡
Seizure 0 (0.0) 0 (0.0) 2 (3.8) 1.000‡
Others 3 (4.8) 2 (4.3) 2 (3.8) 0.967†
Immediate cause of death, n (%)
Pneumonia 33 (52.4) 22 (52.4) 15 (28.8) 0.007†
Cerebrovascular accident 5 (8.1) 1 (2.2) 4 (7.7) 0.188†
Heart failure 5 (7.9) 1 (2.4) 4 (7.7) 1.000‡
Respiratory failure 2 (3.2) 5 (10.9) 6 (11.5) 0.053†
Renal failure 5 (8.1) 6 (13.0) 11 (21.2) 0.046†
Failure on liver, gallbladder, pancreas 2 (3.2) 0 (0.0) 0 (0.0) 1.000‡
Malignant neoplasm 6 (9.7) 0 (0.0) 4 (7.7) 1.000‡
Sepsis 4 (6.5) 3 (6.5) 6 (11.5) 0.228†
Sudden unexpected natural death 0 (0.0) 3 (7.1) 0 (0.0) 0.610‡
Seizure 1 (1.6) 0 (0.0) 1 (1.9) 1.000‡
Others 4 (6.5) 2 (4.3) 3 (5.8) 0.791†
†χ2 test. ‡Fisher’s exact test. AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; VaD, vascular dementia.
Table 3 Clinical time-course of dementia patients with AD, DLB, and VaD (n = 157)
AD DLB VaD
P-value†n = 63 n = 42 n = 52
Age of dementia onset 79 (72–84) 78 (72–84) 76 (70–82) 0.269
Age of death 86 (82–92) 87 (81–92) 83 (78–87) 0.018
Total years (from onset to death) 8 (5–13) 8 (5–15) 5 (3–9) 0.015
According to pneumonia complication
With pneumonia (n = 137) 8 (5–13) 8 (5–14) 5 (3–8) 0.006
Without pneumonia (n = 20) 7 (3–12) 13 (5–18) 5 (3–12) 0.181
According to groups of dementia onset age <0.001
<65 years (n = 17) 17 (13–22) 16 (15–19) 7 (3–11)
65–74 years (n = 36) 11 (8–13) 12 (8–16) 7 (4–12)
≥75 years (n = 102) 6 (4–10) 6 (4–10) 5 (3–6)
Years between dementia onset to admission 6 (2–8) 5 (3–8) 3 (1–6) 0.015
Years between hospital admission to death 2 (1–5) 3 (1–8) 3 (1–5) 0.404
Time-course on each variable is presented as median (interquartile range), years. †Kruskal–Wallis test. AD, Alzheimer’s disease; DLB, dementia with Lewy bodies;
VaD, vascular dementia.
Pneumonia and prognosis of dementia
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Kaplan–Meier method and compared between the dif-
ferent subtypes of dementia with the log-rank test
(Fig. 2). The evaluation of dementia patients (n = 157)
and dementia patients with pneumonia (n = 137)
revealed significant differences among the subtypes of
dementia (P < 0.001 and P = 0.002, respectively)
(Fig. 2a,b). However, there were no significant differ-
ences among the subtypes of dementia in the patients
without pneumonia (Fig. 2c).
In the subgroup analysis, the influence of the com-
plication of pneumonia on clinical time-courses was
also assessed among different age groups by the
Kaplan–Meier method using the log-rank test (Fig. 3).
It was observed that the dementia patients aged
≥75 years with pneumonia had shorter survival times
than those aged <65 years and 65–74 years with
pneumonia. Although the number of patients without
pneumonia was small, there was no significant differ-
ence among in dementia duration among the different
age groups.
Evaluation of risk factors: time to death from
dementia onset
Risk factors relating to survival time in dementia
patients according to the Cox proportional
hazard model
Factors relating to the survival time of dementia were
evaluated with the Cox proportional hazard model for
dementia patients with and without pneumonia (n =
157). The results indicated that the risk factors asso-
ciated with shorter survival time were male gender,
pneumonia, diabetes mellitus, being ≥75 years at the
age of dementia onset, and VaD. Being <65 years at
onset was associated with longer survival time. The
interaction of pneumonia and the dementia subtypes
was also examined by this model, but no statistical
significance was observed.
DISCUSSION
Using neuropathological diagnoses of dementia, the
present study revealed that patients with all three
major subtypes of dementia had a high incidence of
complications with pneumonia. The median total sur-
vival time of dementia onset was 8 years for AD and
DLB and 5 years for VaD. Patients with VaD had a
shorter survival time than those with AD and DLB.
Factors associated with a shorter survival time among
dementia patients were male gender, pneumonia
complications, diabetes mellitus, being ≥75 years at
onset, and VaD.
The World Health Organization has reported that
47.5 million people have dementia and that 7.7 million
new cases occur every year.37 Currently, medications
for treating dementia are limited. The development of
optimal clinical management strategies for dementia
is urgent in order to help patients live a long life.
Figure 2 Kaplan–Meier curves on the number of years to death from dementia onset for dementia patients of each subtype: (a) all dementia
patients; (b) dementia patients with pneumonia; and (c) dementia patients without pneumonia. There were significant differences among all
patients (log-rank test, P < 0.001) and patients with pneumonia (log-rank test, P = 0.002), but not among patients without pneumonia
(log-rank test, P = 0.660).
T. Manabe et al.
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Pneumonia is the leading cause of death in ageing
populations and, in the present study, was the main
cause of death of dementia patients, which is consis-
tent with the results of previous autopsy studies.4,5
Evaluating the effect of pneumonia on the lifespan for
dementia patients is also crucial. However, reported
survival times vary among dementia patients. The
effect of pneumonia on survival time and the differ-
ences among dementia subtypes are also unclear.
Previous reports indicated that the mean survival
time among DLB patients ranged from 1.8 to 9.5
years.18 Another study found that the mean survival
time after an AD diagnosis ranged from 8 to 12
years.17 A previous retrospective study on AD found
that the median survival from initial diagnosis was 4.2
years for men and 5.7 years for women.38 In the
present study, the median survival time was 8 years
for AD and DLB patients and 5 years for VaD patients.
One reason for the differences in survival time
between AD and DLB may be the accuracy of the
clinical diagnosis of dementia. Although differentiation
between the clinical diagnosis of dementia and post-
mortem diagnosis has been discussed,39 most previ-
ous studies have lacked autopsy confirmation for the
specific subtype of dementia. In the present study, the
subtypes of dementia were neuropathologically diag-
nosed and the survival time of dementia evaluated.
The results of the present study found that AD and
DLB had a similar mean duration (7.1 years) to AD
cases in a post-mortem study,40 but the duration was
slightly longer than the 6.1 years found in a meta-
analysis of DLB.18 Another reason for the difference
in survival times between this study and previous
studies was the definition of initiation of dementia. In
our evaluation, disease duration began at the time of
disease onset, not from the time of diagnosis. In a
previous study, similar results were found between AD
and DLB patients when disease duration was exam-
ined from disease onset to death, but when duration
began at the time of diagnosis, the results significantly
differed.16 When disease duration is examined, an
informant (i.e. a friend or family member of the patient)
may need to indicate when initial awareness of con-
ditions and symptoms occurred.
Additionally, we compared the survival time of AD
and DLB patients with that of VaD patients. Although
the aetiopathogenesis of AD, DLB, and VaD are not
completely understood, the differences in survival
times might be due to the different pathogenesis of
each type of dementia. VaD is a progressive disease
Figure 3 Kaplan–Meier curves on the number of years to death from dementia onset for dementia patients in the age groups <65 years,
65–74 years, and ≥75 years: (a) all dementia patients; (b) dementia patients with pneumonia; and (c) dementia patients without pneumonia.
There were significant differences among all patients (log-rank test, P < 0.001) and patients with pneumonia (log-rank test, P < 0.001), but not
among patients without pneumonia (log-rank test, P = 0.208). However, there were only a small number of patients without pneumonia.
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that is caused by reduced cerebral blood flow supply-
ing the brain, and it may be associated with some
types of cerebral events.41–43 In the present study,
cerebral infarction was a more common comorbidity
in VaD than in AD and DLB (P < 0.001). Both AD and
DLB are neurodegenerative disease, and they may
have a slower progression than expansion of cerebral
dysfunction of VaD. In addition, VaD involves systemic
vascular changes, and it is reasonable to suppose
that these changes, in part, contribute to the shorten-
ing of survival time. In the present study, cerebral
vascular changes were more common in patients with
AD than those with DLB; however, there was no dif-
ference in survival time between AD and DLB patients,
but there was a difference between AD and DLB
patients and those with VaD.
Regardless of the subtype of dementia, many
dementia patients experienced the complication of
pneumonia. One reason was that dementia patients
may have weakened defence mechanisms for pre-
venting respiratory tract infections. Previous studies
revealed an association between respiratory function
and cognition, which is impaired in dementia.9–11 Once
dementia patients have experienced pneumonia, the
deterioration of respiratory function may also reduce
lifespan. A recent study examining the association
between respiratory function and the incidence of
pneumonia indicated that for every standard deviation
increase in forced expiratory volume in 1 s, the risk of
dementia decreased by more than 20%.12 Our study
evaluated the association between pneumonia not
only for death but also for survival in patients with
dementia. Swallowing dysfunctions are common in
patients with dementia and known as a major con-
tributor to the mortality.44 In this study, among AD,
DLB, and VaD patients, the presentation of swallow-
ing dysfunctions in each subtype of dementia did not
significantly differ (Table 1). This was not evaluated as
an influencing factor on survival time, but the results
of this study may indicate that swallowing dysfunction
is a risk to mortality and survival time in patients with
dementia, regardless dementia subtype. The survival
time of patients with DLB and pneumonia was 5 years
shorter than that of patients with DLB and no pneu-
monia, but it should be noted that the number of DLB
patients without pneumonia was small. In contrast,
similar survival times were observed between AD and
VaD patients with and without pneumonia (Table 3).
This result suggested that if patients with DLB get
pneumonia, the deterioration of respiratory function
may be faster than in other subtypes of dementia. This
may be because DLB decreased ventilator response
to hypercapnia.45 However, further investigations are
needed to clarify this hypothesis.
The Cox proportional hazard model in the present
study revealed that male gender, pneumonia com-
plication, comorbidity of diabetes mellitus, being
≥75 years at dementia onset, and VaD were indepen-
dent risk factors relating to the shortness of survival
time in dementia patients. Age <65 years at dementia
onset increased survival time (Table 4). Previously,
those with type 2 diabetes mellitus were known to
have a higher risk of dementia than the general popu-
lation.46,47 The present study evaluated diabetes mel-
litus and found that it is a risk for survival time of
dementia patients. The results of the present study
suggested the importance of clinical management of
repetitive pneumonia and underlying diseases, includ-
ing diabetes mellitus, during hospitalization of demen-
tia patients, especially patients aged ≥75 years, to
expand patients’ lifespans.
One limitation of this study was that the time of
onset was taken from the medical records and relied
on reports from patients, their families, or their care-
givers about the commencement of symptoms and
signs of dementia. The present study was conducted
at an institute specializing in psychogerontology, par-
ticularly for patients with dementia. The physicians
were specialists with significant clinical experience
in consulting with dementia patients. It was thought
that time discrepancies with regard to actual onset
thought to be no wide range with their report. This
Table 4 Risk factors for time to mortality from dementia onset in
dementia patients using Cox proportional hazard model (n = 157)
HR 95%CI P-value
Male gender 1.942 1.362–2.769 <0.001
Pneumonia 1.528 0.935–2.496 0.091
Diabetes mellitus 1.585 1.017–2.470 0.042
Age of dementia onset, <65 years 0.372 0.189–0.734 0.004
Age of dementia onset, ≥75 years 2.266 1.507–3.408 0.000
Vascular dementia 2.041 1.397–2.982 0.000
Baseline adjustment covariates: gender, pneumonia complication, subtypes
of dementia (Alzheimer’s disease, dementia with Lewy bodies, vascular
dementia), groups of onset age (<65 years, 65–74 years, ≥75 years), pneu-
monia complication, comorbidities (hypertension, diabetes mellitus, heart
failure, cerebral infarction, pulmonary emphysema, angina, malignant neo-
plasm), swallowing dysfunction, urinary tract infection, and percutaneous
endoscopic gastrostomy. Presented items of P < 0.1.
The interaction of pneumonia and subtypes of dementia was not significant
(P = 0.340). CI, confidence interval; HR, hazard ratio. P value: χ2 test.
T. Manabe et al.
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study was conducted at a single medical institution,
so further studies are required in other populations
before the results can be generalized. We believe this
is the first report comparing the survival time of AD,
DLB, and VaD patients with and without pneumonia in
Japan.
In conclusion, the incidence of pneumonia was
high in three different subtypes of dementia and rep-
resented an immediate cause of death in patients.
Pneumonia complication was a significant factor for
disease prognosis in dementia patients. To maximize
life expectancy, the prevention of pneumonia and
appropriate clinical management of underlying dis-
eases are necessary in dementia patients aged
≥75 years. These results warrant a further prospective
cohort study.
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